(Press-News.org) MSU has a satellite uplink/LTN TV studio and Comrex line for radio interviews upon request.
Contact: Kim Ward: (734) 224-8377, kward@msu.edu
Images
Why this matters:
Scientists use satellite images of light given off by plants — called solar-induced fluorescence, or SIF — to check how healthy the Amazon forest is. SIF is often used to estimate how much photosynthesis is happening. But this study shows that SIF may not be a reliable predictor of photosynthesis functionality. When the climate is stressful, like during a drought, leaves might still glow more even though their ability to photosynthesize is diminished. This could lead scientists to think the forest is doing better than it really is.
The findings offer a first-of-its-kind, high-resolution look at how the Amazon canopy navigates seasonal extremes.
Understanding how trees manage light energy is important worldwide, as the Amazon plays a vital role in global climate regulation, recycling moisture into rainfall and storing vast amounts of carbon.
EAST LANSING, Mich. – In a recent study published in New Phytologist, researchers at Michigan State University have uncovered how Amazon rainforest canopy trees manage the intense sunlight they absorb — revealing resilience to hot and dry conditions in the forest canopy while also offering a way to greatly improve the monitoring of canopy health under increasing extreme conditions. The study was made possible by funding from the National Science Foundation and NASA.
The study, led by doctoral candidate Leonardo Ziccardi with Associate Professor Scott Stark in the MSU Department of Forestry, shows how tropical trees act like giant solar antennas — absorbing vast quantities of light energy that must be carefully managed. When trees absorb more energy than they can use for photosynthesis, it must be safely dissipated, either as heat or re-emitted as light — a process called chlorophyll fluorescence.
“It’s been a long journey,” said Ziccardi. “Since 2019, we’ve run multiple field campaigns across seasons, climbing giant trees in the heart of the Amazon to understand how these forests respond to environmental changes. We’ve spent hundreds of hours up in the canopy doing measurements —some of the most intense and rewarding work I’ve ever done.”
Ziccardi spent more than four years climbing trees nearly 200 feet tall in the central Amazon, measuring the fates of absorbed photons in thousands of leaves across many species, canopy heights, and light exposure conditions, producing a truly unique and unprecedented dataset.
Using a revolutionary handheld instrument — the MultispeQ, developed at MSU by co-author David Kramer in the MSU-DOE Plant Research Laboratory — Ziccardi captured how leaves in natural settings balance incoming light with their ability to photosynthesize or dissipate excess energy.
The findings offer a first-of-its-kind, high-resolution look at how the Amazon canopy navigates seasonal extremes. As the Amazon experiences increasing stress, due to both greenhouse gases and deforestation leading to hotter and drier conditions in the canopy, understanding how trees manage light energy is essential to predicting their future survival. Not only does this climate change lead to greater physiological stress due to more frequent extreme conditions related to lower soil water availability and dry and hot air, it also can increase the amount of sunlight hitting the forest. This happens because drier conditions have less clouds and that lets more sunlight through. This study helps address whether Amazon trees can absorb and use this extra light under stressful conditions.
Despite facing intense sunlight and atmospheric dryness, many canopy leaves were able to continue photosynthesizing, but only by increasing their allocation to energy dissipation pathways. For the first time in the Amazon, the study revealed a nuanced, three-phase response of leaves to rising light and drought conditions. Under low to moderate light, leaves balance energy use between photosynthesis and fluorescence, so these processes tend to increase and decrease together. As light and drought stress increase, however, this balance breaks down. Heat-protective dissipation mechanisms become overwhelmed, photosynthesis drops, and fluorescence can spike — signaling potential damage to the photosynthetic machinery.
The implications are critical for scientists using satellite observations of fluorescence — the so-called solar-induced fluorescence, or SIF — to monitor Amazon forest health. While SIF is often used as a proxy for photosynthesis, this study shows that photosynthesis and fluorescence do not always go up and down together. Under high light and stress, this relationship breaks down and leaves may fluoresce more even as their photosynthetic machinery declines, potentially leading to overestimates of ecosystem productivity during droughts.
By Lauren Noel
###
Michigan State University has been advancing the common good with uncommon will for 170 years. One of the world’s leading public research universities, MSU pushes the boundaries of discovery to make a better, safer, healthier world for all while providing life-changing opportunities to a diverse and inclusive academic community through more than 400 programs of study in 17 degree-granting colleges.
For generations, Spartans have been changing the world through research. Federal funding helps power many of the discoveries that improve lives and keep America at the forefront of innovation and competitiveness. From lifesaving cancer treatments to solutions that advance technology, agriculture, energy and more, MSU researchers work every day to shape a better future for the people of Michigan and beyond. Learn more about MSU’s research impact powered by partnership with the federal government.
For MSU news on the web, go to MSUToday or x.com/MSUnews
END
Amazon trees under pressure: New study reveals how forest giants handle light and heat
2025-06-13
ELSE PRESS RELEASES FROM THIS DATE:
Cell-depleting treatment in severe RMD: New data
2025-06-13
The first of the selected abstracts came from Wolfgang Merkt, who presented an update on a patient who originally received third-generation CD19-CAR-T cells in 2022. This patient had a rapidly progressive form of systemic sclerosis (SSc) with interstitial lung disease with fatal prognosis. The authors report that CAR-T cells and B cell depletion persisted over 24 months, with stable serological remission and major disease improvement. Of note, fibrotic lesions and areas of activated fibroblasts further regressed in ...
Vasodilation in systemic sclerosis
2025-06-13
Most VVD in clinical trials have been shown to exert anti-fibrotic effects – but findings are mixed around whether they also improve pulmonary function tests and prevent progression of SSc-associated interstitial lung disease (ILD). A post-hoc analysis presented by Adela-Cristina Sarbu aimed to address this by assessing the impact of VVD on functional progression and all-cause mortality in people with SSc-ILD. Using data from the EUSTAR database, they looked at three different outcomes for 2,156 people receiving endothelin-receptor antagonists (ERA), phosphodiesterase-5 ...
New ideas in gout management
2025-06-13
Gout flares are associated with cardiovascular events. Treating gout to target serum urate level prevents flares, but whether such treatment can also prevent cardiovascular events is unknown. An abstract from Edoardo Cipolletta and colleagues explored whether achieving serum urate levels of less than 360 μmol/L within 1 year of the first prescription of urate-lowering therapy has an effect on the 5-year risk of major adverse cardiovascular events (MACE). The authors used English and Swedish primary-care data linked to hospitalisation and mortality records for over 116,000 patients. Overall, 16,201 patients had a MACE ...
Risk factors for progression in spondyloarthritis
2025-06-13
Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic musculoskeletal disease that predominantly affects the axial skeleton.1 axSpA is an umbrella term that comprises the whole spectrum of patients with and without radiographic sacroiliitis, and joint ASAS/EULAR recommendations were published in 2022.2 Radiographic sacroiliitis classifies patients as radiographic axSpA (r-axSpA) and those patients are at risk of spinal ankyloses. High disease activity has previously been linked to accelerated radiographic spinal progression in patients with early axSpA,3 but more information is needed.
Work presented at the 2025 annual ...
Patient experiences In JIA
2025-06-13
A systematic review aimed to assess the specific needs for adolescents and young adults with juvenile idiopathic arthritis (JIA). Data from 1,913 patients aged range 11–30 years found that the three most common general needs were around daily activities and involvement in treatment decisions – each cited by 66% - and social life, including family and sexual considerations, which affected 55%. Other key needs in increasing order of importance were mobility, future, education, disease management, and treatment. Of the studies that focused on mental health, the need for independence, emotional ...
Patient organizations: The partner by your side
2025-06-13
At the 2025 congress of EULAR – The European Alliance of Associations for Rheumatology – two abstracts were presented that showcase how patient organisations can help to support with education for people with an RMD.
The first looked at the idea of ‘introduction maps’. To do this, patient experts and healthcare professionals working with ReumaNet in Belgium researched the information needs of new RMD patients. The results suggested a need for high-quality information with one distribution ...
Nurses: A critical role for people with RMD
2025-06-13
New studies shared at the 2025 annual EULAR congress in Barcelona reinforce that position, highlighting the benefits that nurse-led care can bring for both patients and healthcare systems.
Nurse-led care and self-monitoring can both support treat-to-target (T2T) approaches.2,3 Combining self-monitoring with nurse support during the initiation of urate-lowering therapy in people with gout could help reduce physician visits and costs while maintaining or improving quality of care. Work shared by Jeffrey van der Ven looked at estimating the cost-effectiveness ...
Online information for patients needs guidance
2025-06-13
Recommendations stress that communication impacts treatment outcomes and shared decision-making between patients and physicians. Health literacy is an important aspect in this regard, and a person’s understanding of their condition can impact how they are able to use health information.2 There is growing evidence to suggest that internet-based information is an important tool for improving communication with healthcare professionals – and for many patients it plays a central role in their experience.3
New work presented at the 2025 annual EULAR ...
The many ways that AI enters rheumatology
2025-06-13
High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential to improve the quantification and characterisation of SSc-ILD, making it a powerful tool for monitoring. Francesca Motta offered new data from an observational study pitting AI-assisted analysis against two radiologists with expertise in thoracic imaging. Results showed that the AI outperformed visual scoring in assessing the progression of fibrosis in patients with SSc-ILD, and showed more significant correlation with values from pulmonary ...
Pregnancy outcomes in autoinflammatory disease
2025-06-13
To address this, a French multi-centre prospective pregnancy observational cohort was set up, to analyse disease activity, treatment, pregnancy outcomes, delivery, and neonatal health. The work – presented at the 2025 annual congress of EULAR – showcased findings from 97 women with an autoinflammatory disease. The most common diagnoses were FMF (81%), followed by undifferentiated systemic autoinflammatory diseases (USAID), tumour necrosis factor receptor-associated periodic syndrome (TRAPS), cryopyrin-associated periodic syndromes (CAPS), Still's disease, recurrent pericarditis, mevalonate kinase deficiency, A20 haploinsufficiency, and other ...